[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Benef](https://github.com/mm80843/T3.5/tree/pages/docs/Benef/index.md) >> Individual ID:PBN__Benef_61 

# __Data analysis efficiency__

## Articles mentionning this Benefit

* [CIDO, a community-based ontology for coronavirus disease knowledge and data integration, sharing, and analysis](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_13.md)

## Category to which it belongs

* [Access to diverse, comprehensive, and accurate data enables efficient analysis and informed decision-making while ensuring data integrity and security.](https://github.com/mm80843/T3.5/blob/pages/PBNCategory/PBN__PBNCategory_9.md)

## Description of actual returns pertaining to this benefit

* [Private investors can benefit from the improved efficiency in data analysis, leading to faster and more accurate identification of effective measures against coronaviruses, potentially resulting in valuable products or treatments.](https://github.com/mm80843/T3.5/blob/pages/BenefReturn/PBN__BenefReturn_61.md)

## Name of the Benefit

Development of efficient bioinformatics tools enables the integration and analysis of heterogeneous data, improving effectiveness in discovering effective measures against coronaviruses.

## Risks which can benefit from this action

* [Development of bioinformatics tools](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_54.md)

## Stakeholders benefitting from this Benefit

* [Researchers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_46.md)
* [Scientists](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2.md)

